These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 23681440)
1. Response: 'Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin'. McIntush EW EMBO Rep; 2013 Jun; 14(6):494-6. PubMed ID: 23681440 [No Abstract] [Full Text] [Related]
2. Antibody crossreactivity between the tumour suppressor PHLPP1 and the proto-oncogene β-catenin. Lobert VH; Bruun J; Abrahamsen H; Lothe RA; Stenmark H; Kolberg M; Campsteijn C EMBO Rep; 2013 Jan; 14(1):10-1. PubMed ID: 23229585 [No Abstract] [Full Text] [Related]
3. Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells. Suljagic M; Laurenti L; Tarnani M; Alam M; Malek SN; Efremov DG Leukemia; 2010 Dec; 24(12):2063-71. PubMed ID: 20861921 [TBL] [Abstract][Full Text] [Related]
4. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis. Chen H; Zhang K; Wu G; Song D; Chen K; Yang H Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799 [TBL] [Abstract][Full Text] [Related]
5. PHLPP1 is a metastasis suppressor in melanoma. Dai M; Yu Y Aging (Albany NY); 2018 Sep; 10(9):2214-2215. PubMed ID: 30187888 [No Abstract] [Full Text] [Related]
6. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt. Li X; Yang H; Liu J; Schmidt MD; Gao T EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506 [TBL] [Abstract][Full Text] [Related]
7. Detection of PHLPP1α/β in human and mouse brain by different anti-PHLPP1 antibodies. Jackson TC; Bayir H; Ikonomovic MD; Janesko-Feldman K; Mi Z; Gao T; Jackson EK; Kochanek PM Sci Rep; 2015 Apr; 5():9377. PubMed ID: 25827478 [TBL] [Abstract][Full Text] [Related]
8. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells. Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999 [TBL] [Abstract][Full Text] [Related]
9. PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Molina JR; Agarwal NK; Morales FC; Hayashi Y; Aldape KD; Cote G; Georgescu MM Oncogene; 2012 Mar; 31(10):1264-74. PubMed ID: 21804599 [TBL] [Abstract][Full Text] [Related]
10. beta-TrCP-mediated ubiquitination and degradation of PHLPP1 are negatively regulated by Akt. Li X; Liu J; Gao T Mol Cell Biol; 2009 Dec; 29(23):6192-205. PubMed ID: 19797085 [TBL] [Abstract][Full Text] [Related]
11. PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation. Yu Y; Dai M; Lu A; Yu E; Merlino G Oncogene; 2018 Apr; 37(17):2225-2236. PubMed ID: 29391600 [TBL] [Abstract][Full Text] [Related]
12. Akt activation by PHLPP1 ablation prevents pathological hypertrophy by promoting angiogenesis. Li M; Hirsch E Cardiovasc Res; 2015 Feb; 105(2):129-30. PubMed ID: 25538154 [No Abstract] [Full Text] [Related]
13. PHLPPing through history: a decade in the life of PHLPP phosphatases. Grzechnik AT; Newton AC Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677 [TBL] [Abstract][Full Text] [Related]
14. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation. Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor-alpha upregulated PHLPP1 through activating nuclear factor-kappa B during myocardial ischemia/reperfusion. Tang B; Ma J; Ha X; Zhang Y; Xing Y Life Sci; 2018 Aug; 207():355-363. PubMed ID: 29940243 [TBL] [Abstract][Full Text] [Related]
16. The expression patterns and correlations of chibby, β-catenin, and DNA methyltransferase-1 and their clinicopathological significance in lung cancers. Xu HT; Li QC; Dai SD; Xie XM; Liu DI; Wang EH APMIS; 2011 Nov; 119(11):750-8. PubMed ID: 21995627 [TBL] [Abstract][Full Text] [Related]
17. Oncogenic suppression of PHLPP1 in human melanoma. Dong L; Jin L; Tseng HY; Wang CY; Wilmott JS; Yosufi B; Yan XG; Jiang CC; Scolyer RA; Zhang XD; Guo ST Oncogene; 2014 Sep; 33(39):4756-66. PubMed ID: 24121273 [TBL] [Abstract][Full Text] [Related]
18. Lysosomal mTORC2/PHLPP1/Akt axis: a new point of control of chaperone-mediated autophagy. Arias E Oncotarget; 2015 Nov; 6(34):35147-8. PubMed ID: 26436591 [No Abstract] [Full Text] [Related]
19. Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression. Teng DC; Sun J; An YQ; Hu ZH; Liu P; Ma YC; Han B; Shi Y Int Immunopharmacol; 2016 May; 34():229-234. PubMed ID: 26971226 [TBL] [Abstract][Full Text] [Related]
20. Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation. Bradley EW; Carpio LR; Newton AC; Westendorf JJ J Biol Chem; 2015 Jun; 290(26):16272-80. PubMed ID: 25953896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]